Permanent Neonatal Diabetes Caused by Dominant, Recessive, or Compound Heterozygous SUR1 Mutations with Opposite Functional Effects

This publication has 20 references indexed in Scilit:

• Activating Mutations in theABCC8Gene in Neonatal Diabetes Mellitus
  New England Journal of Medicine, 2006
• Functional Effects of Mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), Causing Neonatal Diabetes, and Response to Sulfonylurea Therapy
  Diabetes, 2006
• A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes
  Human Molecular Genetics, 2006
• Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype
  Diabetologia, 2006
• From molecule to malady
  Nature, 2006
• Activating Mutations in Kir6.2 and Neonatal Diabetes
  Diabetes, 2005
• Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
  Diabetes, 1998
• The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide
  The EMBO Journal, 1997
• RET mutations in human disease
  Trends in Genetics, 1996
• Cross sectional stature and weight reference curves for the UK, 1990.
  Archives of Disease in Childhood, 1995